ni ni ni ni ni ni
Edition by Elena Bablenis Haveles
ni ni ni ni ni
CompleteTestBanki
n i
n
,Chapter01:InformationSources, Regulatory Agencies,Drug Legislation,and Prescription Writing
ni ni ni ni ni ni ni ni ni ni
Haveles:AppliedPharmacologyfortheDentalHygienist,9thEdition
i
n i
n ni i
n i
n ni i
n i
n
MULTIPLE CHOICE ni
1. Knowledge of pharmacologyaids the dental professional in ni ni ni ni ni ni ni
a. obtaininga patient’s health history. ni ni ni ni
b. administeringdrugs in the office. ni ni ni ni
c. handlingemergencysituations. ni ni
d. selection ofa nonprescription medication. ni ni ni ni
e. All of the above. ni ni ni
ANS: n i E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
pharmacologyhelpsin understandingand interpretingpatients’ responses to health historyquestions.
ni ni ni ni ni ni ni ni ni ni ni ni
Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
ni ni ni ni ni ni ni ni ni ni ni ni ni ni
administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
knowledge of pharmacology is of great help, especially because a rapid response is sometimes required. A
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
clear understanding of the concepts of drug action, drug handling by the body, and drug interactions will
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
allow the dental practitioner to make proper judgments and grasp the concepts relevant to new drug
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
therapies on the market.
ni ni ni ni
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
n i ni ni ni ni ni ni ni ni ni ni ni ni
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist
ni ni ni ni ni ni ni ni ni ni ni ni ni
(Nonprescription Medication) | pp. 2-3
ni OBJ: 1 ni ni ni ni
TOP: NBDHE, 6.0. Pharmacology n i ni ni
2. Which of the following statements is true regarding planning appointments?
ni ni ni ni ni ni ni ni ni
a. Whetheror not patients are taking medication for systemic diseases is of little ni ni ni ni ni ni ni ni ni ni ni ni
consequencein the dental office. ni ni ni ni
b. Asthmatic patients should have dental appointments in the morning. ni ni ni ni ni ni ni ni
c. Diabetic patientsusuallyhavefewer problems with a morning appointment ni ni ni ni ni ni ni ni ni
compared with afternoon appointments.
ni ni ni ni
d. Both B and C aretrue. ni ni ni ni ni
ANS: n i D
Asthmatic patients who experience dentalanxietyshould schedule their appointments when they are not
ni ni ni ni ni ni ni ni ni ni ni ni ni
rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
with a morning appointment. Patients taking medicationfor systemicdiseases mayrequire special handling
ni ni ni ni ni ni ni ni ni ni ni ni ni ni
in the dental office.
ni ni ni ni
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |p. 3
n i ni ni ni ni ni ni ni ni ni
OBJ: 1
ni TOP: NBDHE, 6.0. Pharmacology
n i n i ni ni
,3. Nutritional or herbal supplements ni ni ni
a. carrythe U.S. Food and Drug Administration (FDA) approval for disease states. ni ni ni ni ni ni ni ni ni ni ni
b. arenot drugs. ni ni
c. can cause adverse effects. ni ni ni
d. will not interact with otherdrugs the patient maybe taking. ni ni ni ni ni ni ni ni ni ni
ANS: n i C
Nutritional or herbal supplements are quite capableof causing adverse effects. The majorityof nutritional or ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
herbal supplements do not carry FDA approval for treating disease states. These supplements are drugs and
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
can cause adverse effects and interact with different drugs.
ni ni ni ni ni ni ni ni ni
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |p. 3
n i ni ni ni ni ni ni ni ni ni ni ni
OBJ: 1
ni TOP: NBDHE, 6.0. Pharmacology
n i n i ni ni
4. Whichtype of drug name usuallybegins with a lowercase letter?
ni ni ni ni ni ni ni ni ni ni
a. Brandname ni
b. Code name ni
c. Genericname ni
d. Tradename ni
ANS: n i C
Before anydrug is marketed, it is given a generic name that becomes the “official” name ofthe drug. Each
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
technicallythe name of the companymarketingthe product, this term is often used interchangeably with the
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
trade name. The code name is the initial term used within a pharmaceutical company to refer to a drug while
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
it is undergoing investigation and is often a combination of capital letters and numbers, the letters
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
representing an abbreviation of the company name.
ni ni ni ni ni ni ni
DIF: Comprehension REF: DrugNames |p. 4 n i ni ni ni ni
OBJ: 3
ni TOP: n i n i NBDHE, 6.0. Pharmacology ni ni
5. A drug’s genericname is selected bythe
ni ni ni ni ni ni ni
a. pharmaceutical company manufacturingit. ni ni ni
b. Food and Drug Administration (FDA). ni ni ni ni
c. U.S. Adopted Name Council. ni ni ni
d. Federal Patent Office. ni ni
ANS: n i C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
companymanufacturingthe drug clearlyhas an influence on the generic name given its drug, but the final
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
decision is not the company’s.
ni ni ni ni ni
DIF: Recall REF: Drug Names | p. 4 n i ni ni ni ni OBJ:
n3 TOP: NBDHE, 6.0. Pharmacology
i ni n i ni ni
6. Whichof the following is true concerninggeneric and tradenames of drugs?
ni ni ni ni ni ni ni ni ni ni ni ni
a. A drug mayonly have one generic name and one trade name.
ni ni ni ni ni ni ni ni ni ni ni
, b. A drug mayonly have one generic name, but it may have several trade names.
ni ni ni ni ni ni ni ni ni ni ni ni ni ni
c. A drug may have several generic names, but it may only have one trade name.
ni ni ni ni ni ni ni ni ni ni ni ni ni ni
d. A drug may have several generic names and several trade names.
ni ni ni ni ni ni ni ni ni ni
ANS: n i B
Each drug has only one generic name but may have several trade names. For each drug, there is only one
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
company discovering the drug gives the drug a trade name. The trade name is protected bythe Federal Patent
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
Lawfor 20 years from the earliest claimed filing date, plus patent term extensions. Although the brand name
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
is technicallythe name of the companymarketingthe product, it is often used interchangeably with the trade
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
name.
ni
DIF: Comprehension REF: DrugNames |p. 4 n i ni ni ni ni
OBJ: 3
ni TOP: n i n i NBDHE, 6.0. Pharmacology ni ni
7. Two drugs that are found to be chemicallyequivalent, but not biologicallyequivalent or
ni ni ni ni ni ni ni ni ni ni ni ni ni
ni therapeutically equivalent are said to differ in ni ni ni ni ni ni
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticindex. ni
ANS: n i C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
ni ni ni ni ni ni ni ni ni ni ni ni
products are said to differ in their bioavailability. The potencyof a drug is a function of the amount of drug
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
required to produce an effect. The efficacy is the maximum intensity of effect or response that can be
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental animals
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic index is
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
small, toxicity is more likely.
ni ni ni ni ni
DIF: Recall REF: n i DrugNames (Drug Substitution) |p. 5 ni ni ni ni ni ni
OBJ: 4
ni n i TOP: n i NBDHE, 6.0. Pharmacology ni ni
8. How many years must pass after a drug patent expires before other drug companies can market the same
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
compound as a generic drug?
ni ni ni ni ni
a. 20 years ni
b. 17 years ni
c. 7 years ni
d. 0 years ni
ANS: n i D
Once a drug patent expires, competing companies may immediately market the same compound in generic
ni ni ni ni ni ni ni ni ni ni ni ni ni ni
form. The pharmaceutical company discovering the drug gives the drug a trade name. The tradenameis
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
protectedby the Federal Patent Lawfor 20 years from the earliest claimed filingdate, plus the patent term
ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni ni
extensions.
ni
DIF: Application REF: n i DrugNames (Drug Substitution) |p. 5 ni ni ni ni ni ni
OBJ: 4
ni n i TOP: n i NBDHE, 6.0. Pharmacology ni ni